Table 4. Blood parameters pre- and post-fasting.
All (n = 1422) |
F5d 5±2 d |
F10d 10±2 d |
F15d 15±2 d |
F20d 20±2 d |
p-values | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pre | post | pre | post | pre | post | Pre | post | pre | post | fasting inter- vention |
fasting dura- tion group |
sex | fasting dura- tion group-by-fasting inter- vention |
fasting inter- vention-by-sex |
|
INR | 0.99±0.00 | 1.08±0.00 | 0.98±0.00 | 1.06±0.00 | 0.99±0.01 | 1.09±0.01 | 0.99±0.02 | 1.11±0.02 | 0.98±0.01 | 1.10±0.02 | <0.001 | <0.001 | 0.84 | <0.001 | ‒ |
Quick, % | 104.3±0.3 | 91.4±0.3 | 104.2±0.5 | 92.9±0.4 | 104.0±0.6 | 90.6±0.5 | 105.6±1.0 | 89.1±0.9 | 104.1±1.2 | 88.3±1.9 | <0.001 | <0.001 | 0.33 | <0.001 | 0.005 |
PTT, sec | 31.1±0.1 | 32.7±0.1 | 31.1±0.1 | 32.4±0.1 | 31.0±0.1 | 32.8±0.2 | 31.2±0.2 | 33.7±0.3 | 31.4±0.4 | 32.9±0.5 | <0.001 | <0.001 | 0.88 | <0.001 | ‒ |
GOT, μkat/L | 0.4±0.0 | 0.6±0.0 | 0.4±0.0 | 0.6±0.0 | 0.4±0.0 | 0.6±0.0 | 0.4±0.0 | 0.6±0.0 | 0.4±0.0 | 0.7±0.0 | <0.001 | 0.73 | 0.007 | ‒ | <0.001 |
GPT, μkat/L | 0.5±0.0 | 0.7±0.0 | 0.5±0.0 | 0.6±0.0 | 0.5±0.0 | 0.7±0.0 | 0.5±0.0 | 0.7±0.0 | 0.6±0.0 | 0.8±0.1 | <0.001 | 0.07 | 0.65 | 0.10 | ‒ |
GGT, μkat/L | 0.6±0.0 | 0.4±0.0 | 0.5±0.0 | 0.4±0.0 | 0.6±0.1 | 0.4±0.0 | 0.6±0.1 | 0.4±0.0 | 0.5±0.1 | 0.4±0.01 | <0.001 | <0.001 | 0.18 | <0.001 | <0.001 |
AP, μkat/L | 1.1±0.0 | 1.0±0.0 | 1.0±0.0 | 1.0±0.0 | 1.1±0.0 | 1.1±0.0 | 1.1±0.0 | 1.0±0.0 | 1.2±0.1 | 1.1±0.1 | <0.001 | <0.001 | 0.003 | <0.001 | 0.002 |
CRP, mg/L | 2.85±0.14 | 4.30±0.20 | 2.49±0.19 | 4.11±0.27 | 3.02±0.28 | 4.35±0.36 | 3.37±0.32 | 4.74±0.63 | 4.08±0.67 | 4.67±0.82 | 0.001 | 0.97 | 0.99 | 0.81 | 0.53 |
ESR 1h | 11.6±0.2 | 11.4±0.2 | 10.9±0.3 | 11.7±0.3 | 11.8±0.4 | 11.5±0.4 | 12.8±0.7 | 10.6±0.6 | 15.1±1.6 | 10.2±1.4 | <0.001 | <0.001 | 0.002 | <0.001 | <0.001 |
ESR 2h | 21.7±0.4 | 21.3±0.4 | 20.4±0.5 | 21.8±0.5 | 22.1±0.6 | 21.4±0.6 | 23.9±1.1 | 19.7±1.0 | 28.2±2.8 | 20.1±2.4 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Uric acid, μmol/L | 338.1±2.3 | 495.2±4.4 | 334.0±3.3 | 481.1±6.0 | 339.2±3.8 | 505.5±7.5 | 345.3±6.4 | 513.0±13.5 | 355.9±12.8 | 505.4±30.6 | <0.001 | 0.01 | <0.001 | 0.01 | <0.001 |
Urea, mmol/L | 4.7±0.0 | 3.1±0.0 | 4.6±0.1 | 3.3±0.1 | 4.7±0.1 | 3.0±0.1 | 4.7±0.1 | 2.7±0.1 | 5.1±0.3 | 2.8±0.3 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Creatinine, μmol/L | 71.92±0.40 | 76.43±0.54 | 72.53±0.58 | 76.45±0.76 | 71.88±0.68 | 76.88±1.00 | 69.86±0.98 | 74.98±1.21 | 72.27±2.53 | 77.17±3.13 | <0.001 | 0.34 | <0.001 | ‒ | <0.001 |
Na,mmol/L | 140.1±0.1 | 138.7±0.1 | 140.0±0.1 | 138.4±0.1 | 140.1±0.1 | 138.8±0.1 | 139.8±0.3 | 139.2±0.2 | 141.0±0.33 | 139.9±0.4 | <0.001 | <0.001 | 0.37 | 0.003 | ‒ |
K, mmol/L | 4.4±0.0 | 4.4±0.0 | 4.4±0.0 | 4.4±0.0 | 4.4±0.0 | 4.4±0.0 | 4.3±0.0 | 4.4±0.0 | 4.4±0.1 | 4.4±0.1 | 0.001 | 0.74 | <0.001 | ‒ | 0.008 |
Ca, mmol/L | 2.32±0.00 | 2.38±0.00 | 2.33±0.00 | 2.36±0.00 | 2.32±0.00 | 2.39±0.00 | 2.32±0.01 | 2.39±0.01 | 2.33±0.02 | 2.40±0.02 | <0.001 | <0.001 | 0.14 | <0.001 | ‒ |
Mg, mmol/L | 0.86±0.00 | 0.87±0.00 | 0.87±0.00 | 0.89±0.00 | 0.87±0.00 | 0.87±0.00 | 0.85±0.00 | 0.86±0.01 | 0.86±0.01 | 0.85±0.01 | 0.09 | <0.001 | <0.001 | <0.001 | <0.001 |
Values are shown as mean±SEM for all of the groups with different fasting lengths. P-values were calculated for the effects of fasting (fasting intervention) as well as the effects of the fasting length (fasting duration group) and gender (sex). Interactions between fasting intervention by fasting duration group (fasting duration group-by-fasting intervention) and fasting intervention by gender (fasting intervention-by-sex) are shown.
INR, international normalized ratio; PTT, partial thromboplastin time; GOT, serum glutamic oxaloacetic transaminase; GPT, serum glutamate pyruvate transaminase; GGT, serum gamma-glutamyl transferase; AP, alkaline phosphatase; CRP, C-reactive protein; ESR 1h, erythrocyte sedimentation rate after 1 hour; ESR 2h, erythrocyte sedimentation rate after 2 hours; Na, sodium; K, potassium; Ca, calcium, Mg, magnesium